Natera (NTRA) Capital Expenditures Growth (1y) (2015 - 2026)
Natera (NTRA) Capital Expenditures Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.96 Bn | 209.90 Bn | 8.34 Bn | 53.06% |
| 2 | Danaher | 140.29 Bn | 135.94 Bn | 3.61 Bn | 8.47% |
| 3 | Idexx Laboratories | 46.08 Bn | 45.88 Bn | 779.09 Mn | -27.73% |
| 4 | Agilent Technologies | 39.78 Bn | 37.97 Bn | 990.00 Mn | -33.33% |
| 5 | Iqvia Holdings | 39.43 Bn | 37.35 Bn | 1.44 Bn | 31.13% |
| 6 | Natera | 38.72 Bn | 37.62 Bn | 696.04 Mn | 1.48% |
| 7 | Illumina | 30.05 Bn | 28.88 Bn | 770.00 Mn | 33.33% |
| 8 | Mettler Toledo International | 28.63 Bn | 28.58 Bn | 650.22 Mn | 16.40% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | 27.78% |
| 10 | Labcorp Holdings | 25.89 Bn | 24.91 Bn | 1.01 Bn | -3.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.48% |
| Dec 31, 2025 | 99.09% |
| Sep 30, 2025 | 37.35% |
| Jun 30, 2025 | -18.77% |
| Mar 31, 2025 | 19,377.68% |
| Dec 31, 2024 | 80.24% |
| Sep 30, 2024 | 82.11% |
| Jun 30, 2024 | 71.62% |
| Mar 31, 2024 | -93.06% |
| Dec 31, 2023 | -15.01% |
| Sep 30, 2023 | -73.53% |
| Jun 30, 2023 | 30,554.10% |
| Mar 31, 2023 | -23.04% |
| Dec 31, 2022 | -67.21% |
| Sep 30, 2022 | 12,478.07% |
| Jun 30, 2022 | 98.91% |
| Mar 31, 2022 | -79.57% |
| Dec 31, 2021 | 114.85% |
| Sep 30, 2021 | 103.68% |
| Jun 30, 2021 | -174.56% |